Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra-sensitive detection system, Simoa®, can potentially change the approach to healthcare today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Simoa is designed to enable earlier disease detection, better prognosis, and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for applications in therapeutic areas including oncology, neurology, cardiology, inflammation and infectious disease.
Brands: Simoa® HD-1 Analyzer, SR-X™ Ultra-Sensitive Biomarker Detection System, SP-X™ Imaging and Analysis System, Simoa® Bead-Based and Planar Assays